Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque Psoriasis
Clinical trial NCT04279119 · COMPLETED
Trial details
- NCT number
- NCT04279119
- Sponsor
- Arcutis Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-10
- Primary completion
- 2021-03-25
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.